Skip to main content
Home

oAv Menu

  • Home
  • Patient Care Center
  • Clinical Trials
  • Providers
    • Therapeutics
    • People
    • Places
  • Community Center
    • Community Stories
    • Social Media
    • Community Content
    • Financial Assistance
  • News
    • Community Events
    • Clinical Trials and Research
    • Business
    • News People
    • Happenings
    • Spotlight
    • Fundraising Events
  • Trusted Resources
    • Education
    • Videos & Visuals
  • Event Calendar
  • Login
  • Search

Patient Education

  1. Home
  2. Trusted Resources
  3. Education
  4. Patient Education
National Library of Medicine
Feb 10, 2024
Needs of amyloidosis patients and their care providers: design & first results of the AMY-NEEDS research and care program
Read more
Jan 29, 2023
Long-term survival in people with transthyretin amyloid cardiomyopathy who took tafamidis: a plain language summary
Read more
Dec 28, 2022
CRISPR’s Quest to Slay Donegal Amy
Read more
Mar 16, 2022
How Did Transthyretin Amyloid Cardiomyopathy Progress in Patients Who Took Placebo in the Study ATTR-ACT? A Plain Language Summary
Read more
Feb 03, 2022
Genetic Testing and Counseling for hATTR Amyloidosis
Read more
Jan 31, 2022
Living With Amyloidosis
Read more
Jul 31, 2021
AL Amyloidosis: Your Essential Guide
Read more
Apr 13, 2021
Lay Summary of “Expert Analysis and Opinion—Understanding Cardiac Amyloidosis”
Read more
Feb 03, 2021
Coral – My 17 Years Living With AL Amyloidosis
Read more
Jan 24, 2021
Frequently Asked Questions About COVID-19 Vaccination
Read more

Pagination

  • « First First page
  • ‹‹ Previous page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • ›› Next page
  • Last » Last page
Subscribe to

Newsletter

Stay informed - subscribe to our newsletter.
The subscriber's email address.

Expert and Community Perspectives on Attruby®

In this special session, Dr. Barry Trachtenberg and members of the ATTR amyloidosis community came together to share medical insights and lived experiences related to Attruby™ (acoramidis). This expert-led discussion explores the clinical data, the patient perspective, and what lies ahead for those considering or currently taking Attruby.

Subscribe

Featured Trials

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ALN-TTRSC04 in Healthy Subjects
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis

Footer menu

  • Home
  • About us
  • Video
  • Galleries
  • Contact
  • Login
  • Privacy Policy
  • Privacy Reminder
  • Terms of use
  • FAQ
  • Code of Conduct

© 2025 Somebody To Talk To, Inc.

Join us on